Adherence to ASCO/CAP HER2 Testing Guidelines: Equivocal Rates and Impact on Management within a Single Institution

被引：0
|
作者：
Portier, B. P.
Downs-Kelly, E.
Lanigan, C.
Cotta, C.
Patil, D.
Procop, G.
Cook, J. R.
Moore, H.
Budd, G. T.
Tubbs, R. R.
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Taussig Canc Inst, Cleveland, OH USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1856
引用
收藏
页码：436A / 436A
页数：1
相关论文
共 50 条
  • [1] Adherence to ASCO/CAP HER2 Testing Guidelines: Equivocal Rates and Impact on Management within a Single Institution
    Portier, B. P.
    Downs-Kelly, E.
    Lanigan, C.
    Cotta, C.
    Patil, D.
    Procop, G.
    Cook, J. R.
    Moore, H.
    Budd, G. T.
    Tubbs, R. R.
    MODERN PATHOLOGY, 2011, 24 : 436A - 436A
  • [2] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
    Xu, Fang-Ping
    Wang, Kun
    Xu, Jie
    Chen, Jie
    Zhang, Yi-Fang
    Wu, Hong-Mei
    Zhang, Ming-Hui
    Long, Xiao-Xu
    Luo, Xin-Lan
    Zhang, Ke-Ping
    Lin, Dan-Yi
    Liu, Yan-Hui
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (03) : 757 - 764
  • [3] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines
    Fang-Ping Xu
    Kun Wang
    Jie Xu
    Jie Chen
    Yi-Fang Zhang
    Hong-Mei Wu
    Ming-Hui Zhang
    Xiao-Xu Long
    Xin-Lan Luo
    Ke-Ping Zhang
    Dan-Yi Lin
    Yan-Hui Liu
    Breast Cancer Research and Treatment, 2017, 166 : 757 - 764
  • [4] Outcome of Repeat HER2 Testing After Initial Equivocal HER2 FISH Results Using 2013 ASCO/CAP Guidelines and Implications for Impact of Updated 2018 ASCO/CAP in Similar Cases
    Malone, V.
    Walker, J.
    Castriciano, G.
    Maguire, A.
    JOURNAL OF PATHOLOGY, 2020, 250 : 7 - 7
  • [5] 2018 ASCO/CAP Her2 Testing Guidelines in Breast Cancer. Impact of the Updated Guidelines on Breast Carcinomas Originally Classified as Her2 Equivocal - A Retrospective Analysis
    Alzeer, Ali
    Zeck, Jay
    Laureano, Julio
    Sidawy, Mary
    LABORATORY INVESTIGATION, 2019, 99
  • [6] Impact of the 2018 ASCO/CAP HER2 guidelines update for HER2 testing by FISH in breast cancer
    Xu, Bin
    Shen, Jianguo
    Guo, Wenhao
    Zhao, Wenhe
    Zhuang, Yiyu
    Wang, Linbo
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (02) : 251 - 255
  • [7] 2018 ASCO/CAP Her2 Testing Guidelines in Breast Cancer. Impact of the Updated Guidelines on Breast Carcinomas Originally Classified as Her2 Equivocal - A Retrospective Analysis
    Alzeer, Ali
    Zeck, Jay
    Laureano, Julio
    Sidawy, Mary
    MODERN PATHOLOGY, 2019, 32
  • [8] Impact of modified 2013 ASCO/CAP guidelines on HER2 testing in breast cancer
    Varga, Z.
    Noske, A.
    BREAST, 2015, 24 : S108 - S108
  • [9] The Impact of 2013 ASCO/CAP Guidelines on the Practice of HER2 Testing in a Reference Laboratory
    Hanna, Wedad
    Slodkowska, Elzbieta
    Lu, Fang-I
    Han, Guangming
    Nafisi, Houman
    Nofech-Mozes, Sharon
    MODERN PATHOLOGY, 2016, 29 : 44A - 44A
  • [10] Impact of the updated 2018 ASCO/CAP guidelines for HER2 testing in breast cancer
    Li, Anqi
    Bai, Qianming
    Zhou, Xiaoyan
    Yang, Wentao
    LABORATORY INVESTIGATION, 2019, 99
12345